MERCATELLI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 1.166
EU - Europa 243
AS - Asia 133
SA - Sud America 2
Totale 1.544
Nazione #
US - Stati Uniti d'America 1.166
IT - Italia 89
CN - Cina 86
TR - Turchia 38
GB - Regno Unito 31
AT - Austria 22
DE - Germania 22
UA - Ucraina 22
SE - Svezia 20
FI - Finlandia 17
BE - Belgio 7
PL - Polonia 6
FR - Francia 4
VN - Vietnam 3
IQ - Iraq 2
RO - Romania 2
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
IR - Iran 1
JP - Giappone 1
PH - Filippine 1
TW - Taiwan 1
Totale 1.544
Città #
Fairfield 167
Woodbridge 157
Chandler 133
Ashburn 108
Houston 106
Ann Arbor 81
Wilmington 67
Seattle 66
Cambridge 58
Beijing 38
Jacksonville 35
Ferrara 30
Milan 22
Princeton 22
Vienna 22
Izmir 20
Shanghai 12
Lappeenranta 10
Nanjing 10
Boardman 7
Brussels 7
Morciano Di Romagna 7
San Diego 7
Nanchang 6
Shenyang 6
Warsaw 6
Norwalk 5
Auburn Hills 4
Bremen 4
Changsha 3
Dong Ket 3
Ferrara di Monte Baldo 3
Frankfurt am Main 3
Los Angeles 3
Addison 2
Des Moines 2
Kunming 2
London 2
Monterenzio 2
Muggia 2
Ningbo 2
Orange 2
Tappahannock 2
Zhengzhou 2
Ardabil 1
Baghdad 1
Basra 1
Bordeaux 1
Canda 1
Chiswick 1
Clearwater 1
Edinburgh 1
Falls Church 1
Florence 1
Haikou 1
Hebei 1
Hounslow 1
Istanbul 1
Jiaxing 1
Manila 1
Pamplona 1
Philadelphia 1
Prescot 1
Quito 1
Redwood City 1
Sanayi 1
Taipei 1
Taiyuan 1
Tianjin 1
Washington 1
Totale 1.284
Nome #
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity 187
Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells 164
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 143
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists 138
Knock-in mice with NOP-eGFP receptors identify receptor cellular and regional localization 105
AT-1001: A high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology 103
N/OFQ system in brain areas of nerve-injured mice: its role in different aspects of neuropathic pain 99
Parkinson's disease: no NOP, new hope 88
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4 84
NOP receptor ligands and Parkinson’s disease 78
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes 75
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling 62
Managing Parkinson's disease: moving ON with NOP 55
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 44
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models 37
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity 32
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 29
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia 21
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice 21
Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo 17
Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse 14
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model 6
Totale 1.602
Categoria #
all - tutte 7.888
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 380
Totale 8.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019110 0 0 0 0 0 0 0 0 0 0 48 62
2019/2020418 38 14 13 43 25 70 40 42 51 25 41 16
2020/2021261 17 29 6 12 26 10 16 36 10 37 35 27
2021/2022172 3 15 6 2 6 21 18 12 5 19 25 40
2022/2023299 23 49 11 44 42 30 25 19 29 0 17 10
2023/2024108 18 13 6 9 11 17 7 13 3 11 0 0
Totale 1.602